🔴 HCW Biologics is trading 8.88% down in pre-market after a $1.5 million private placement

HCW Biologics is trading at $1.81, down 8.88%, after announcing a $1.5 million private placement on September 24, 2026.

• The financing includes 903,614 pre-funded warrants and potential common warrants, creating dilution concerns.
• Shares had gained 19.88% during the September 24 regular session before the financing-related reversal.
• Proceeds will support clinical trials, development programs, and general corporate purposes.